Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial

BACKGROUND: Although the generic drug approval process has a long-term successful track record, concerns remain for approval of narrow therapeutic index generic immunosuppressants, such as tacrolimus, in transplant recipients. Several professional transplant societies and publications have generated...

Descripción completa

Detalles Bibliográficos
Autores principales: Alloway, Rita R., Vinks, Alexander A., Fukuda, Tsuyoshi, Mizuno, Tomoyuki, King, Eileen C., Zou, Yuanshu, Jiang, Wenlei, Woodle, E. Steve, Tremblay, Simon, Klawitter, Jelena, Klawitter, Jost, Christians, Uwe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685573/
https://www.ncbi.nlm.nih.gov/pubmed/29135993
http://dx.doi.org/10.1371/journal.pmed.1002428

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685573/
https://www.ncbi.nlm.nih.gov/pubmed/29135993
http://dx.doi.org/10.1371/journal.pmed.1002428

Ejemplares similares